Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ NovoCure Ltd.
NovoCure Ltd.
Industry · 19 registered clinical trials —
2 currently recruiting
.
Status
Trial
Phase
Started
Recruiting
TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER
Glioblastoma
—
2024-01-11
Active Not Recruiting
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel a
Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2
2023-08-28
Recruiting
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Pleural Mesothelioma
—
2023-08-01
Unknown
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
Glioblastoma
—
2021-12-30
Completed
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Tre
Glioblastoma Multiforme
N/A
2020-12-08
Completed
Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of U
Gastric Cancer, GastroEsophageal Cancer
N/A
2019-12-19
Completed
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Re
Ovarian Cancer
Phase 3
2019-03-22
Completed
Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carc
Hepatocellular Carcinoma
Phase 2
2019-02-15
Completed
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Ade
Pancreas Adenocarcinoma
Phase 3
2018-05-10
Unknown
TTFields In GErmany in Routine Clinical Care
Glioblastoma
—
2017-08-31
Unknown
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
Glioblastoma Multiforme
N/A
2017-04-27
Completed
Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignan
Malignant Pleural Mesothelioma
Phase 2
2015-02-01
Unknown
Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian C
Ovarian Carcinoma
Phase 1 / Phase 2
2014-09-01
Unknown
Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabi
Pancreatic Adenocarcinoma
Phase 1 / Phase 2
2013-11-01
Unknown
Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following
1-5 Brain Metastases From Non-Small Cell Lung Cancer
Phase 2
2013-01-01
Terminated
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
Recurrent Glioblastoma Multiforme
Phase 4
2012-12-01
Completed
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Glioblastoma Multiforme
Phase 3
2009-06-01
Completed
NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer
Non-small Cell Lung Cancer, NSCLC
Phase 1 / Phase 2
2008-05-01
Completed
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
Recurrent Glioblastoma Multiforme
Phase 3
2006-09-01